547 related articles for article (PubMed ID: 9624531)
1. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.
Foster K; Prowse A; van den Berg A; Fleming S; Hulsbeek MM; Crossey PA; Richards FM; Cairns P; Affara NA; Ferguson-Smith MA
Hum Mol Genet; 1994 Dec; 3(12):2169-73. PubMed ID: 7881415
[TBL] [Abstract][Full Text] [Related]
3. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours.
Crossey PA; Foster K; Richards FM; Phipps ME; Latif F; Tory K; Jones MH; Bentley E; Kumar R; Lerman MI
Hum Genet; 1994 Jan; 93(1):53-8. PubMed ID: 8270255
[TBL] [Abstract][Full Text] [Related]
5. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
Prowse AH; Webster AR; Richards FM; Richard S; Olschwang S; Resche F; Affara NA; Maher ER
Am J Hum Genet; 1997 Apr; 60(4):765-71. PubMed ID: 9106522
[TBL] [Abstract][Full Text] [Related]
6. Involvement of multiple loci on chromosome 3 in renal cell cancer development.
van den Berg A; Buys CH
Genes Chromosomes Cancer; 1997 Jun; 19(2):59-76. PubMed ID: 9171996
[TBL] [Abstract][Full Text] [Related]
7. Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development.
van den Berg A; Dijkhuizen T; Draaijers TG; Hulsbeek MM; Maher ER; van den Berg E; Störkel S; Buys CH
Genes Chromosomes Cancer; 1997 Aug; 19(4):228-32. PubMed ID: 9258657
[TBL] [Abstract][Full Text] [Related]
8. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma.
Chino K; Esumi M; Ishida H; Okada K
J Urol; 1999 Aug; 162(2):614-8. PubMed ID: 10411097
[TBL] [Abstract][Full Text] [Related]
9. Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas.
Lubinski J; Hadaczek P; Podolski J; Toloczko A; Sikorski A; McCue P; Druck T; Huebner K
Cancer Res; 1994 Jul; 54(14):3710-3. PubMed ID: 8033088
[TBL] [Abstract][Full Text] [Related]
10. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
11. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
Zbar B
Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization.
Moch H; Schraml P; Bubendorf L; Richter J; Gasser TC; Mihatsch MJ; Sauter G
Cancer Res; 1998 Jun; 58(11):2304-9. PubMed ID: 9622063
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations in sporadic renal-cell carcinoma: molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p.
Brauch H; Pomer S; Hieronymus T; Schadt T; Löhrke H; Komitowski D
World J Urol; 1994; 12(3):162-8. PubMed ID: 7951344
[TBL] [Abstract][Full Text] [Related]
14. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
Whaley JM; Naglich J; Gelbert L; Hsia YE; Lamiell JM; Green JS; Collins D; Neumann HP; Laidlaw J; Li FP
Am J Hum Genet; 1994 Dec; 55(6):1092-102. PubMed ID: 7977367
[TBL] [Abstract][Full Text] [Related]
15. The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells.
Koochekpour S; Jeffers M; Wang PH; Gong C; Taylor GA; Roessler LM; Stearman R; Vasselli JR; Stetler-Stevenson WG; Kaelin WG; Linehan WM; Klausner RD; Gnarra JR; Vande Woude GF
Mol Cell Biol; 1999 Sep; 19(9):5902-12. PubMed ID: 10454537
[TBL] [Abstract][Full Text] [Related]
16. [Hippel-Lindau syndrome and sporadic renal cell carcinomas. Pathogenesis, morphologic spectrum and molecular genetics].
Brauch H; Böhm J; Höfler H
Pathologe; 1995 Sep; 16(5):321-7. PubMed ID: 7479604
[TBL] [Abstract][Full Text] [Related]
17. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.
Chung DC; Smith AP; Louis DN; Graeme-Cook F; Warshaw AL; Arnold A
J Clin Invest; 1997 Jul; 100(2):404-10. PubMed ID: 9218518
[TBL] [Abstract][Full Text] [Related]
18. Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer.
Waber PG; Lee NK; Nisen PD
Oncogene; 1996 Jan; 12(2):365-9. PubMed ID: 8570213
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic studies of sporadic and familial renal cell carcinoma.
Gnarra JR; Glenn GM; Latif F; Anglard P; Lerman MI; Zbar B; Linehan WM
Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic analysis of the von Hippel-Lindau disease (VHL) tumour suppressor gene in gonadal tumours.
Foster K; Osborne RJ; Huddart RA; Affara NA; Ferguson-Smith MA; Maher ER
Eur J Cancer; 1995 Dec; 31A(13-14):2392-5. PubMed ID: 8652274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]